Leopoldo Baiza Durán, MD
Laboratorios Sophia S.A de C.V.
12
0
10
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+9 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
Fung-Rong Hu, MD
National Taiwan University Hospital
Shared therapeutic areas:
Gerhard Garhoefer, MD
Department of Clinical Pharmacology, Medical University of Vienna
Shared therapeutic areas:
Oliver Findl, MD
Vienna Institute for Research in Ocular Surgery
Shared therapeutic areas:
Louis Tong, Phd
Singapore National Eye Centre
Shared therapeutic areas:
Gerhard Garhöfer, MD
Department of Clinical Pharmacology, Medical University of Vienna
Shared therapeutic areas:
William C. Stewart, MD
Pharmaceutical Research Network, LLC
Shared therapeutic areas:
Gail Torkildsen, MD
Andover Eye Associates
Shared therapeutic areas:
Tim McNamara, PharmD
ISTA Pharmaceuticals, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
Clinical Trial to Compare the Safety and Efficacy of Nanodrop®
Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution
Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®
Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®
Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification
Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.
Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel
Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects
Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.
Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.
Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects
Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension
All 12 trials loaded